Psycho-educational CBT-Insomnia workshops in the community. A cost-effectiveness analysis alongside a randomised controlled trial

Behaviour Research and Therapy

Volumn 55, Issue 1, 2014, Pages 40-47

  Bonin, Eva Maria ^a   Beecham, Jennifer ^a,b   Swift, Naomi ^c   Raikundalia, Shriti ^c   Brown, June S L ^c  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^b UNIVERSITY OF KENT   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

CEAC; Cognitive behaviour therapy; Cost effectiveness; Costs and cost analysis; Group intervention; Insomnia; Self referral; WTP

Indexed keywords

ADULT; ARTICLE; COGNITIVE THERAPY; COMMUNITY CARE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; FEMALE; FOLLOW UP; HEALTH CARE ACCESS; HUMAN; INSOMNIA; INSOMNIA SEVERITY INDEX; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; TREATMENT PLANNING; COST BENEFIT ANALYSIS; DEMOGRAPHY; ECONOMICS; EDUCATION; HEALTH CARE COST; PATIENT ATTITUDE; PATIENT EDUCATION; SLEEP INITIATION AND MAINTENANCE DISORDERS; STATISTICAL MODEL; YOUNG ADULT;

ADULT; COGNITIVE THERAPY; COST-BENEFIT ANALYSIS; EDUCATION; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MODELS, ECONOMIC; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION AS TOPIC; RESIDENCE CHARACTERISTICS; SLEEP INITIATION AND MAINTENANCE DISORDERS; YOUNG ADULT;

EID: 84895765866     PISSN: 00057967     EISSN: 1873622X     Source Type: Journal    
DOI: 10.1016/j.brat.2014.01.005     Document Type: Article

References (42)

1. Archer M., Brown J.S., Idusohan H., Coventry S., Manoharan A., Espie C.A. The development and evaluation of a large-scale self-referral CBT-I intervention for men who have insomnia: an exploratory study. Behavioural and Cognitive Psychotherapy 2009, 37:239-248.
2. Bastien C.H., Morin C.M., Ouellet M.C., Blais F.C., Bouchard S. Cognitive-behavioral therapy for insomnia: comparison of individual therapy, group therapy, and telephone consultations. Journal of Consulting and Clinical Psychology 2004, 72:653-659.
3. Bastien C.H., Vallieres A., Morin C.M. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Medicine 2001, 2:297-307.
4. Beecham J. Unit costs - Not exactly child's play. A guide to estimating unit costs for children's social care 2000, Department of Health, Dartington Socian Research Unit, PSSRU, Dartington.
5. Beecham J., Knapp M. Costing psychiatric interventions. Measuring mental health needs 2001, Royal College of Psychiatrists, London. 2nd ed. G. Thornicroft (Ed.).
6. Botteman M. Health economics of insomnia therapy: implications for policy. Sleep Medicine 2009, 10(Suppl 1):S22-S25.
7. Brown I. Involving the public in general practice in an urban district: levels and type of activity and perceptions of obstacles. Health and Social Care in the Community 2000, 8:251-259.
8. Byford S., Knapp M., Greenshields J., Ukoumunne O.C., Jones V., Thompson S., et al. Cost-effectiveness of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: a decision-making approach. Psychological Medicine 2003, 33:977-986.
9. Centre for Economic Performance The depression report: a new deal for depression and anxiety disorders 2006, London School of Economics and Political Science Centre for Economic Performance, London.
10. Curtis L. Unit costs of health and social care 2008 2008, Canterbury: Personal Social Services Research Unit, University of Kent.
11. Daley M., Morin C.M., LeBlanc M., Gregoire J.P., Savard J. The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers. Sleep 2009, 32:55-64.
12. Daley M., Morin C.M., LeBlanc M., Gregoire J.P., Savard J., Baillargeon L. Insomnia and its relationship to health-care utilization, work absenteeism, productivity and accidents. Sleep Medicine 2009, 10:427-438.
13. Department of Health NHS reference costs 2007-08 2009, Department of Health, London.
14. Efron B., Tibshirani R. An introduction to the bootstrap 1993, Vol. 57. Chapman and Hall, New York.
15. Ford D.E., Kamerow D.B. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?. Journal of the American Medical Association 1989, 262:1479-1484.
16. Glick H., Doshi J., Sonnad S., Polsky D. Economic evaluation in clinical trials 2007, Oxford University Press, Oxford.
17. Godet-Cayre V., Pelletier-Fleury N., Le Vaillant M., Dinet J., Massuel M.A., Leger D. Insomnia and absenteeism at work. Who pays the cost?. Sleep 2006, 29:179-184.
18. Hatoum H.T., Kong S.X., Kania C.M., Wong J.M., Mendelson W.B. Insomnia, health-related quality of life and healthcare resource consumption. A study of managed-care organisation enrollees. Pharmacoeconomics 1998, 14:629-637.
19. Hillman D.R., Murphy A.S., Pezzullo L. The economic cost of sleep disorders. Sleep 2006, 29:299-305.
20. Hoch J.S., Briggs A.H., Willan A.R. Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis. Health Economics 2002, 11:415-430.
21. van Hout B.A., Al M.J., Gordon G.S., Rutten F.F. Costs, effects and C/E-ratios alongside a clinical trial. Health Economics 1994, 3:309-319.
22. Kapur V.K., Redline S., Nieto F.J., Young T.B., Newman A.B., Henderson J.A. The relationship between chronically disrupted sleep and healthcare use. Sleep 2002, 25:289-296.
23. Knapp M., Mangalore R. The trouble with QALYs. ... Epidemiologia e psichiatria sociale 2007, 16:289-293.
24. Knutson K.L. Sleep duration and cardiometabolic risk: a review of the epidemiologic evidence. Best practice & research. Clinical Endocrinology & Metabolism 2010, 24:731-743.
25. Krystal A.D. Psychiatric disorders and sleep. Neurologic Clinics 2012, 30:1389-1413.
26. Lamberg L. Despite effectiveness, behavioural therapy for chronic insomnia still under used. Journal of the American Medical Association 2008, 300:2474-2475.
27. Leger D., Guilleminault C., Bader G., Levy E., Paillard M. Medical and socio-professional impact of insomnia. Sleep 2002, 25:625-629.
28. Linton S.J., Bryngelsson I.-L. Insomnia and its relationship to work and health in a working-age population. Journal of Occupational Rehabilitation 2000, 10:169-183.
29. Manca A., Hawkins N., Sculpher M.J. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Economics 2005, 14:487-496.
30. McCrone P., Knapp M., Proudfoot J., Ryden C., Cavanagh K., Shapiro D.A., et al. Cost-effectiveness of computerised cognitive-behavioural therapy for anxiety and depression in primary care: randomised controlled trial. British Journal of Psychiatry 2004, 185:55-62.
31. Morgan K., Dixon S., Mathers N., Thompson J., Tomeny M. Psychological treatment for insomnia in the regulation of long-term hypnotic drug use. Health Technology Assessment 2004, 8(iii-iv):1-68.
32. Morin C.M., Espie C.A. Insomnia: a clinical guide to assessment and treatment 2003, Klewer Academic/Plenum, New York.
33. Morin C.M., LeBlanc M., Daley M., Gregoire J.P., Merette C. Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Medicine 2006, 7:123-130.
34. National Institute for Health and Clinical Excellence Guide to the methods of technology appraisal 2008, NICE, London.
35. O'Brien B.J., Briggs A.H. Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods. Statistical Methods in Medical Research 2002, 11:455-468.
36. Ozminkowski R.J., Wang S., Walsh J.K. The direct and indirect costs of untreated insomnia in adults in the United States. Sleep 2007, 30:263-273.
37. Patel A., Rendu A., Moran P., Leese M., Mann A., Knapp M. Acomparison of two methods of collecting economic data in primary care. Family Practice 2005, 22:323-327.
38. Roth T., Ancoli-Israel S. Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. II. Sleep 1999, 22(Suppl.2):S354-S358.
39. Singleton N., Bumpstead R., O'Brien M., Lee A., Meltzer H. Psychiatric morbidity among adults living in private households, 2000 2001, Office for National Statistics, London.
40. Stewart R., Besset A., Bebbington P., Brugha T., Lindesay J., Jenkins R., et al. Insomnia comorbidity and impact and hypnotic use by age group in a national survey population aged 16 to 74 years. Sleep 2006, 29:1391-1397.
41. Swift N., Stewart R., Andiappan M., Smith A., Espie C.A., Brown J.S. The effectiveness of community day-long CBT-I workshops for participants with insomnia symptoms: a randomised controlled trial. Journal of Sleep Research 2012, 21(3):270-280.
42. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990, 16:199-208. The EuroQol Group.